- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Bayer's heart failure drug bound for NHS on NICE recommendation | ||
| Fr | FDA grants traditional approval to Novartis' Fabhalta for IgAN | ||
| Fr | MSD wins FDA approval for cholesterol pill to help plug Keytruda void | ||
| Fr | JCVI issues recommendation on adolescent MenB vaccination in UK | ||
| Do | UK commits to pharma IP protection in Swiss trade deal | ||
| Do | Novo secures European approval for oral Wegovy to extend lead over Lilly | ||
| Do | Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover | ||
| Do | Big pharma-backed AdvanCell pockets $315m to progress RLT to Phase III | ||
| Do | Telix opens radiopharmaceutical facility in Australia for cancer treatment | ||
| Do | Harbour BioMed and Kelun-Biotech receive China IND approval for asthma therapy | ||
| Mi | J&J raises FY26 outlook following positive Q2 | ||
| Mi | Women's health attracted record equity in 2025 as companies share capital | ||
| Mi | AAIC26: The role of biomarkers in primary care and early diagnostics | ||
| Mi | FDA grants priority review to Roche's Gazyva/Gazyvaro for pMN | ||
| Mi | Innovent licenses IBI355 rights to Spero for up to $1.1bn | ||
| Di | AstraZeneca pays up to $1.5bn to license Dizal Pharma's lung cancer drug | ||
| Di | Novartis and Chai Discovery collaborate on antibody identification | ||
| Di | Cellares and Sonoma partner to automate cell therapy manufacturing | ||
| Mo | Germany approves healthcare costs overhaul despite significant pharma opposition | ||
| Mo | "Hub-and-spoke" drug manufacturing set to benefit from new FDA rule | ||
| Mo | Takeda and Indonesia partner on plasma-derived therapies | ||
| Mo | FDA approves MSD's Keytruda combinations for MIBC | ||
| 10.07. | Bayer banks €3bn in Apollo contraceptives division deal | ||
| 10.07. | Chinese biotech MindRank secures $52m to advance AI-designed oral GLP-1RA | ||
| 10.07. | Ipsen set to rival Botox after duo of Phase III migraine wins |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.